The Effect of Once-Weekly 70 Mg Alendronate Versus Once-Daily 10 Mg Alendronate in the Treatment of Postmenopausal Osteoporosis

The aim of this study was to compare the effect of once-weekly 70 mg alendronate versus once-daily 10 mg alendronate in the treatment of postmenopausal osteoporosis. Sixty-three women with postmenopausal osteoporosis were randomly assigned to two groups. The first group consisting of 26 patients rec...

Full description

Bibliographic Details
Published in:	Türk Osteoporoz Dergisi
Main Authors:	İlker Çorapçı, Cengiz Öner, Onur Armağan, Yavuz Selim Pehlivan, Funda Taşçıoğlu
Format:	Article
Language:	English
Published:	Turkish Society of Osteoporosis 2004-03-01
Subjects:	Postmenopausal osteoporosis alendronate 70 mg alendronate 10 mg application
Online Access:	http://www.turkosteoporozdergisi.org/article_4206/The-Effect-Of-Once-weekly-70-Mg-Alendronate-Versus-Once-daily-10-Mg-Alendronate-In-The-Treatment-Of-Postmenopausal-Osteoporosis

Similar Items

The Effects of Once-Weekly Alendronate 70 mg, Risedronate 35 mg and Raloxifene 60 mg Daily in the Treatment of Postmenopausal Osteoporosis in Turkish Population
by: Mesut Öktem, et al.
Published: (2007-04-01)

The Effect of Alendronate and Calcitonin Treatments on Bone Mineral Density and Quality of Life in Women With Postmenopausal Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2002-06-01)

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01)

Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels
by: Saliha Karatay, et al.
Published: (2005-03-01)

The Effect of Alendronate in Male Osteoporosis
by: Özlem El, et al.
Published: (2004-12-01)

Use of alendronate in the therapy of osteoporosis
by: O. B. Ershova
Published: (2020-01-01)

Two Years of Alendronate and Calcitonin Treatments for Osteoporosis in Postmenopausal Women - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

The Effect of Alendronate and Intranasal Calcitonin Treatments on Bone Mineral Density in Men with Idiopathic Osteoporosis
by: F. Taşçıoğlu, et al.
Published: (2003-03-01)

The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
by: S. Akı, et al.
Published: (2002-03-01)

REVIEW OF BASIC CLINICAL TRIALS OF ALENDRONATE
by: E G Zotkin, et al.
Published: (2010-03-01)

Evaluation of bone remodelling parameters after one year treatment with alendronate in postmenopausal women with osteoporosis
by: Elma Kučukalić-Selimović, et al.
Published: (2011-02-01)

Periodontal and Biochemical Correlations during Alendronate Treatment in Postmenopausal Women: A Longitudinal Study
by: Aseel Jalil Ibrahim Al-Karawi, et al.
Published: (2025-02-01)

A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study
by: Salvatore Minisola, et al.
Published: (2021-07-01)

Irrational use of alendronate sodium by the elderly
by: Camila Pereira Alvim, et al.
Published: (2020-11-01)

Association Between CTSK Gene Polymorphisms and Response to Alendronate Treatment in Postmenopausal Chinese Women with Low Bone Mineral Density
by: Yuan H, et al.
Published: (2023-10-01)

Cost–effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain
by: Enrique Casado, et al.
Published: (2023-09-01)

First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
by: Vishal R Tandon, et al.
Published: (2014-01-01)

The Comparison of Effects of Alendronate and Calcitonin Treatment in Men With Osteoporosis
by: Gülcan Gürer, et al.
Published: (2004-09-01)

Alendronate-associated Polyarticular Synovitis: A Case Report
by: Büşra Şirin, et al.
Published: (2024-04-01)

Efficacy of generic alendronate and ibandronate in post menopausal osteoporosis
by: NP Somasundaram, et al.
Published: (2012-03-01)

An academic clinical study to assess the efficacy and safety of nandrolone decanoate and alendronate compared with alendronate alone in patients with osteoporosis
by: Bharat R Dave, et al.
Published: (2023-01-01)

The comparison of effects of alendronate and raloxifene treatment in postmenauposal women with osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2005-12-01)

Camparision Results of Administration of Glucoseamine and Glucoseamine with Alendronate in Symptomatic Relieve of Knee DJD
by: Hamid Reza Arti, et al.
Published: (2012-11-01)

Mechanistic PK-PD model of alendronate treatment of postmenopausal osteoporosis predicts bone site-specific response
by: José L. Calvo-Gallego, et al.
Published: (2022-08-01)

Effect of Vitamin K and Alendronate Combination Treatment on Bone Mineral Density of Postmenopausal Osteoporosis Patients: A Pilot Study
by: Mohammad Hassan Jokar, et al.
Published: (2016-01-01)

Evaluation of Alendronate Efficacy on Bone Mineral Density in Thalassemic Patients
by: Fatemeh Shirani, et al.
Published: (2012-10-01)

Alendronate overdose/intoxication: Suicidal attempt in a case report
by: T. Gutiérrez Higueras, et al.
Published: (2021-04-01)

Evaluation of Alendronate Efficacy on Bone Mineral Density in Thalassemic Patients
by: Fatemeh Shirani, et al.
Published: (2015-10-01)

Circular RNA atlas in osteoclast differentiation with and without alendronate treatment
by: Jianbiao Lin, et al.
Published: (2020-07-01)

Modern principles for the diagnosis and treatment of postmenopausal osteoporosis: a focus on bisphosphonates
by: I. B. Belyaeva, et al.
Published: (2020-08-01)

The Efficacy of Alendronate Treatment in Ambulatory Stroke Patients
by: Nihal ÖZARAS, et al.
Published: (2016-04-01)

Alendronate-Grafted Nanoemulsions for Bone-Targeted Vincristine Delivery: Preliminary Studies on Cell and Animal Models
by: Ian Stoppa, et al.
Published: (2024-02-01)

Cholesterol nanoarchaeosomes for alendronate targeted delivery as an anti-endothelial dysfunction agent
by: Horacio Emanuel Jerez, et al.
Published: (2024-05-01)

Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal
by: Er-Yuan Liao, et al.
Published: (2018-07-01)

Enhanced osteogenic differentiation of alendronate-conjugated nanodiamonds for potential osteoporosis treatment
by: Guk Young Ahn, et al.
Published: (2021-09-01)

Bone-targeted polymeric nanoparticles as alendronate carriers for potential osteoporosis treatment
by: Chunlan Jing, et al.
Published: (2022-06-01)

Effect of Weekly Alendronate on Knee Symptoms in Patients with Osteoporosis and Knee Osteoarthritis Coexistence - Original Investigation
by: Levent Ediz, et al.
Published: (2010-04-01)

Efficacy and safety of alendronic acid in the treatment of osteoporosis in children
by: Alberto Martín Siguero, et al.
Published: (2015-11-01)

Bioequivalence of Alendronate and Vitamin D3 in a Combination Tablet Versus Corresponding-Dose Individual Tablets in Healthy Taiwanese Volunteers, Determined Using a Novel Plasma Alendronate Assay
by: D. Hamish Wright, PhD, et al.
Published: (2015-12-01)